{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:46:30Z","timestamp":1771479990271,"version":"3.50.1"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004052","name":"King Abdullah University of Science and Technology","doi-asserted-by":"publisher","award":["BAS\/1\/1080-01"],"award-info":[{"award-number":["BAS\/1\/1080-01"]}],"id":[{"id":"10.13039\/501100004052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004052","name":"King Abdullah University of Science and Technology","doi-asserted-by":"publisher","award":["REI\/1\/4742-01"],"award-info":[{"award-number":["REI\/1\/4742-01"]}],"id":[{"id":"10.13039\/501100004052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Viral infectious diseases are significant threats to the welfare of world populations. Besides the widespread acute viral infections (e.g., dengue fever) and chronic infections [e.g., those by the human immunodeficiency virus (HIV) and hepatitis B virus (HBV)], emerging viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), pose great challenges to the world. Genome editing technologies, including clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated (Cas) proteins, zinc-finger nucleases (ZFNs), and transcription activator-like effector nucleases (TALENs), have played essential roles in the study of new treatment for viral infectious diseases in cell lines, animal models, and clinical trials. Genome editing tools have been used to eliminate latent infections and provide resistance to new infections. Increasing evidence has shown that genome editing-based antiviral strategy is simple to design and can be quickly adapted to combat infections by a wide spectrum of viral pathogens, including the emerging coronaviruses. Here we review the development and applications of genome editing technologies for preventing or eliminating infections caused by HIV, HBV, HPV, HSV, and SARS-CoV-2, and discuss how the latest advances could enlighten further development of genome editing into a novel therapy for viral infectious diseases.<\/jats:p>","DOI":"10.3389\/fcell.2021.716344","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T13:27:47Z","timestamp":1626355667000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Genome Editing Technologies as Cellular Defense Against Viral Pathogens"],"prefix":"10.3389","volume":"9","author":[{"given":"Yingzi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"865.e","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nature24049","article-title":"RNA targeting with CRISPR-Cas13.","volume":"550","author":"Abudayyeh","year":"2017","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"aaf5573","DOI":"10.1126\/science.aaf5573","article-title":"C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector.","volume":"353","author":"Abudayyeh","year":"2016","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1021\/jacs.7b11754","article-title":"Endosomal Escape and Delivery of CRISPR\/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework.","volume":"140","author":"Alsaiari","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"B5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ymthe.2005.06.094","article-title":"Custom Zinc-Finger Nucleases for Use in Human Cells.","volume":"12","author":"Alwin","year":"2005","journal-title":"Mole. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.hoc.2017.06.007","article-title":"Nonintegrating Gene Therapy Vectors.","volume":"31","author":"Athanasopoulos","year":"2017","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"B8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.omtn.2018.05.021","article-title":"Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice.","volume":"12","author":"Bella","year":"2018","journal-title":"Mole. Ther."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.12.20129247","article-title":"Simultaneous Detection and Mutation Surveillance of SARS-CoV-2 and co-infections of multiple respiratory viruses by Rapid field-deployable sequencing.","author":"Bi","year":"2021","journal-title":"medRxiv"},{"key":"B10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13059-020-02143-8","article-title":"Long-read individual-molecule sequencing reveals CRISPR-induced genetic heterogeneity in human ESCs.","volume":"21","author":"Bi","year":"2020","journal-title":"Genome Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"10570","DOI":"10.1073\/pnas.95.18.10570","article-title":"FokI dimerization is required for DNA cleavage.","volume":"95","author":"Bitinaite","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.idc.2014.08.007","article-title":"Finding a cure for human immunodeficiency virus-1 infection.","volume":"28","author":"Blankson","year":"2014","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.1178811","article-title":"Breaking the code of DNA binding specificity of TAL-type III effectors.","volume":"326","author":"Boch","year":"2009","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.coi.2018.06.002","article-title":"Harnessing CRISPR to combat human viral infections.","volume":"54","author":"de Buhr","year":"2018","journal-title":"Curr. Opinion Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nature09886","article-title":"CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.","volume":"471","author":"Deltcheva","year":"2011","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.antiviral.2015.03.015","article-title":"Targeting hepatitis B virus cccDNA by CRISPR\/Cas9 nuclease efficiently inhibits viral replication.","volume":"118","author":"Dong","year":"2015","journal-title":"Antiviral. Res."},{"key":"B17","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.molcel.2019.09.013","article-title":"Programmable inhibition and detection of RNA viruses using Cas13.","volume":"76","author":"Freije","year":"2019","journal-title":"Mol. Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1093\/nar\/gkaa226","article-title":"Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA.","volume":"48","author":"Gao","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature09523","article-title":"The CRISPR\/Cas bacterial immune system cleaves bacteriophage and plasmid DNA.","volume":"468","author":"Garneau","year":"2010","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"Olavarria, HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation.","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR\u2013Cas9 genome editing induces a p53-mediated DNA damage response.","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"key":"B22","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1038\/s41467-019-12449-2","article-title":"High levels of AAV vector integration into CRISPR-induced DNA breaks.","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat. Comm."},{"key":"B23","doi-asserted-by":"publisher","first-page":"11461","DOI":"10.1073\/pnas.1405186111","article-title":"RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.","volume":"111","author":"Hu","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B24","doi-asserted-by":"crossref","first-page":"612823","DOI":"10.1155\/2014\/612823","article-title":"Disruption of HPV16-E7 by CRISPR\/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells.","volume":"2014","author":"Hu","year":"2014","journal-title":"BioMed. Res. Internat."},{"key":"B25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.aad6778","article-title":"Editing policy to fit the genome?","volume":"351","author":"Isasi","year":"2016","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product.","volume":"169","author":"Ishino","year":"1987","journal-title":"J. Bacteriol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR\u2013Cas9 Structures and Mechanisms.","volume":"46","author":"Jiang","year":"2017","journal-title":"Ann. Rev. Biophys."},{"key":"B28","doi-asserted-by":"publisher","first-page":"11965","DOI":"10.1128\/jvi.01879-14","article-title":"Inactivation of the Human Papillomavirus E6 or E7 Gene in Cervical Carcinoma Cells by Using a Bacterial CRISPR\/Cas RNA-Guided Endonuclease.","volume":"88","author":"Kennedy","year":"2014","journal-title":"J. Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain.","volume":"93","author":"Kim","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B30","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.1129134","article-title":"Infectious Diseases: Preparing for the Future.","volume":"313","author":"King","year":"2006","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements.","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41563-020-0674-z","article-title":"A year-long extended release nanoformulated cabotegravir prodrug.","volume":"19","author":"Kulkarni","year":"2020","journal-title":"Nat. Material."},{"key":"B33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cell.2015.12.041","article-title":"The Heroes of CRISPR.","volume":"164","author":"Lander","year":"2016","journal-title":"Cell"},{"key":"B34","first-page":"7","article-title":"Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9.","volume":"2017","author":"Li","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1074\/jbc.r113.488247","article-title":"A cut above the rest: targeted genome editing technologies in human pluripotent stem cells.","volume":"289","author":"Li","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B36","first-page":"6413","article-title":"Use of the CRISPR\/Cas9 system as an intracellular defense against HIV-1 infection in human cells.","volume":"6","author":"Liao","year":"","journal-title":"Nat."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1080\/15384101.2015.1046791","article-title":"Stem cell, CRISPR and HIV.","volume":"14","author":"Liao","year":"","journal-title":"Cell Cycle"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo.","volume":"3","author":"Lin","year":"2014","journal-title":"Mole. Ther. Nucleic Acids"},{"key":"B39","doi-asserted-by":"publisher","first-page":"100245","DOI":"10.1016\/j.xcrm.2021.100245","article-title":"A comprehensive analysis and resource to use CRISPR-Cas13 for broad-spectrum targeting of RNA viruses.","volume":"2021","author":"Lin","year":"2021","journal-title":"Cell Reports Medicine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1089\/hum.2015.069","article-title":"Challenges in CRISPR\/CAS9 Delivery: Potential Roles of Nonviral Vectors.","volume":"26","author":"Ling Li","year":"2015","journal-title":"Hum. Gene Ther"},{"key":"B41","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1038\/s41467-020-19821-7","article-title":"CRISPR based editing of SIV proviral DNA in ART treated non-human primates.","volume":"11","author":"Mancuso","year":"2020","journal-title":"Nat. Comm."},{"key":"B42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-018-07845-z","article-title":"Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins.","volume":"10","author":"Mangeot","year":"2019","journal-title":"Nat. Comm."},{"key":"B43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy.","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"B44","year":"2017","journal-title":"National Academy of Sciences Engineering, and Medicine, Human genome editing: science, ethics, and governance."},{"key":"B45","year":"2020","journal-title":"The Royal Society; National Academy of Sciences; National Academy of Medicine; International Commission on the Clinical Use of Human Germline Genome Editing, Heritable Human Genome Editing."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3389","article-title":"Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.","volume":"47","author":"Nault","year":"2015","journal-title":"Nat. Genet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41422-020-0290-0","article-title":"Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses.","volume":"30","author":"Nguyen","year":"2020","journal-title":"Cell Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bj.2019.10.005","article-title":"CRISPR-Cas12a: Functional overview and applications.","volume":"43","author":"Paul","year":"2020","journal-title":"Biomed. J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1126\/science.1078395","article-title":"Chimeric Nucleases Stimulate Gene Targeting in Human Cells.","volume":"300","author":"Porteus","year":"2003","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nbt1125","article-title":"Gene targeting using zinc finger nucleases.","volume":"23","author":"Porteus","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"B51","first-page":"1086","article-title":"Clearing a path for an HIV cure.","volume":"367","author":"Pujanandez","year":"2020","journal-title":"Science"},{"key":"B52","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus.","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci. Rep."},{"key":"B53","doi-asserted-by":"crossref","first-page":"23146","DOI":"10.1038\/srep23146","article-title":"Inhibition of HSV-1 Replication by Gene Editing Strategy.","volume":"6","author":"Roehm","year":"2016","journal-title":"Sci. Rep."},{"key":"B54","first-page":"11","article-title":"Human Immune Responses to Adeno-Associated Virus (AAV) Vectors.","volume":"2020","author":"Ronzitti","year":"2020","journal-title":"Front. Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.omtm.2020.05.001","article-title":"Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates.","volume":"17","author":"Samelson-Jones","year":"2020","journal-title":"Mole. Ther. Methods Clin. Dev."},{"key":"B56","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1038\/s41598-017-07642-6","article-title":"ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells.","volume":"7","author":"Scott","year":"2017","journal-title":"Sci. Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1038\/mtna.2014.68","article-title":"Targeting Hepatitis B Virus With CRISPR\/Cas9.","volume":"3","author":"Seeger","year":"2014","journal-title":"Mole. Ther. Nucleic Acids"},{"key":"B58","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/s41563-020-0731-7","article-title":"Long-acting antiretroviral therapy.","volume":"19","author":"Soriano","year":"2020","journal-title":"Nat. Material."},{"key":"B59","doi-asserted-by":"crossref","first-page":"e1307","DOI":"10.1128\/JCM.01307-18","article-title":"CRISPR-Cas Biology and Its Application to Infectious Diseases.","volume":"57","author":"Strich","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nbt1317","article-title":"Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases.","volume":"25","author":"Szczepek","year":"2007","journal-title":"Nature Biotechnology"},{"key":"B61","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV.","volume":"370","author":"Tebas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B62","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.","volume":"4","author":"Trickey","year":"2017","journal-title":"Lancet HIV"},{"key":"B63","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nrg2842","article-title":"Genome editing with engineered zinc finger nucleases.","volume":"11","author":"Urnov","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e1005701","DOI":"10.1371\/journal.ppat.1005701","article-title":"CRISPR\/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.","volume":"12","author":"van Diemen","year":"2016","journal-title":"PLoS Pathog."},{"key":"B65","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.virusres.2017.07.020","article-title":"CRISPR-Cas based antiviral strategies against HIV-1.","volume":"244","author":"Wang","year":"2018","journal-title":"Virus Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1126\/science.2157286","article-title":"Association of human papillomavirus types 16 and 18 E6 proteins with p53.","volume":"248","author":"Werness","year":"1990","journal-title":"Science"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1056\/nejmoa1817426","article-title":"CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.","volume":"381","author":"Xu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ymthe.2017.03.012","article-title":"In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.","volume":"25","author":"Yin","year":"2017","journal-title":"Mole. Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/nbt.4005","article-title":"Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing.","volume":"35","author":"Yin","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.omtn.2020.05.030","article-title":"CRISPR-Cas13a Inhibits HIV-1 Infection.","volume":"21","author":"Yin","year":"2020","journal-title":"Mole. Ther. Acids"},{"key":"B71","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/ott.s64092","article-title":"Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat\/Cas system in human cervical cancer cells.","volume":"8","author":"Yu","year":"2015","journal-title":"Onco Targets Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nbt.3737","article-title":"Multiplex gene editing by CRISPR\u2013Cpf1 using a single crRNA array.","volume":"35","author":"Zetsche","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System.","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/gt.2015.2","article-title":"Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated Cas9 system to disrupt the hepatitis B virus.","volume":"22","author":"Zhen","year":"2015","journal-title":"Gene Therapy"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.bbrc.2014.07.014","article-title":"In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR\/Cas9.","volume":"450","author":"Zhen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B76","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nchembio.2410","article-title":"Cpf1 proteins excise CRISPR RNAs from mRNA transcripts in mammalian cells.","volume":"13","author":"Zhong","year":"2017","journal-title":"Nat. Chem. Biol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.716344\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T13:28:21Z","timestamp":1626355701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.716344\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":76,"alternative-id":["10.3389\/fcell.2021.716344"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.716344","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"article-number":"716344"}}